Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?

被引：2
|
作者：
Poletajew, Slawomir [1 ]
Krajewski, Wojciech [2 ]
Kryst, Piotr [1 ]
机构：
[1] Ctr Postgrad Med Educ, Dept Urol 2, 80 Ceglowska St, PL-00809 Warsaw, Poland
[2] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2020年 / 9卷 / 06期
关键词：
CISPLATIN-INELIGIBLE PATIENTS; PD-1; BLOCKADE; UROTHELIAL CARCINOMA; CLINICAL-RESPONSE; SOLID TUMORS; SINGLE-ARM; MULTICENTER; SENSITIVITY; EXPRESSION; GUIDELINES;
D O I：
10.21037/tau-20-907
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：2479 / 2482
页数：4
相关论文
共 50 条
  • [1] Chemotherapy Plus Immune Check-Point Inhibitors in Metastatic Bladder Cancer
    Soares, Adriana
    Carmo, Rafael
    Rodrigues, Catarina
    Grilo, Ines Teles
    Grande, Enrique
    BLADDER CANCER, 2020, 6 (01) : 1 - 8
  • [2] Cholangiocarcinoma: Era of Immune Check-Point Inhibitors
    El Hag, Mohamed I.
    Wood-Trageser, Michelle
    Patel, Krishna
    Specht, Susan
    Sasatomi, Eizaburo
    Sun, Weijing
    Demetris, Anthony
    MODERN PATHOLOGY, 2018, 31 : 633 - 633
  • [3] Immune check-point in endometrial cancer
    De Felice, Francesca
    Marchetti, Claudia
    Tombolini, Vincenzo
    Panici, P. Benedetti
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (08) : 910 - 916
  • [4] Cholangiocarcinoma: Era of Immune Check-Point Inhibitors
    El Hag, Mohamed I.
    Wood-Trageser, Michelle
    Patel, Krishna
    Specht, Susan
    Sasatomi, Eizaburo
    Sun, Weijing
    Demetris, Anthony
    LABORATORY INVESTIGATION, 2018, 98 : 633 - 633
  • [5] Immune check-point in endometrial cancer
    Francesca De Felice
    Claudia Marchetti
    Vincenzo Tombolini
    P. Benedetti Panici
    International Journal of Clinical Oncology, 2019, 24 : 910 - 916
  • [6] Immune check-point in cervical cancer
    De Felice, F.
    Marchetti, C.
    Palaia, I.
    Ostuni, R.
    Muzii, L.
    Tombolini, V.
    Panici, P. Benedetti
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 40 - 43
  • [7] Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
    Luke, Jason John
    Ott, Patrick Alexander
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2457 - 2462
  • [8] Immune-related adverse reactions as a result of therapy with check-point inhibitors
    Makowska, Joanna
    Lewandowska-Polak, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2018, 23 (01): : 2 - 6
  • [9] Safety of immune check-point inhibitors in patients with autoimmune conditions and advanced cancer
    Gard, G.
    Van Hagen, T.
    Ariyapperuma, M.
    Feeney, K.
    Roberts-Thomson, R.
    Millward, M.
    Khattak, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Targeted Interleukin 2 and synergy with immune check-point inhibitors
    Hutmacher-Berndt, Cornelia Deborah
    Neri, Dario
    CANCER RESEARCH, 2018, 78 (13)
12345